Gene: CLEC2D
Official Full Name: C-type lectin domain family 2 member Dprovided by HGNC
Gene Summary: This gene encodes a member of the natural killer cell receptor C-type lectin family. The encoded protein inhibits osteoclast formation and contains a transmembrane domain near the N-terminus as well as the C-type lectin-like extracellular domain. Several alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Oct 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03678 | CLEC2D Knockout cell line (HeLa) | Human | CLEC2D | 1:3~1:6 | Negative | Online Inquiry |
KO03679 | CLEC2D Knockout cell line (HCT 116) | Human | CLEC2D | 1:2~1:4 | Negative | Online Inquiry |
KO03680 | CLEC2D Knockout cell line (HEK293) | Human | CLEC2D | 1:3~1:6 | Negative | Online Inquiry |
KO03681 | CLEC2D Knockout cell line (A549) | Human | CLEC2D | 1:3~1:4 | Negative | Online Inquiry |
CLEC2D Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to enable researchers to study the role of the CLEC2D gene in various biological processes. This gene encodes a type of lectin receptor involved in immune responses and is integral for the activation and differentiation of immune cells. By utilizing these knockout cell lines, scientists can effectively investigate the functional consequences of CLEC2D absence, shedding light on its role in immune modulation, disease pathogenesis, and potential therapeutic targets.
Key mechanisms of these cell lines include the disruption of CLEC2D expression, achieved through targeted gene editing techniques such as CRISPR/Cas9. This knockout strategy allows researchers to observe alterations in signaling pathways, cellular interactions, and overall immune response, providing valuable insights into the gene's involvement in specific immunological phenomena.
The scientific importance of CLEC2D Gene Knockout Cell Lines is underscored by their applications in both research and clinical settings. They are invaluable for studying disease models, particularly those involving autoimmune conditions, inflammatory diseases, and cancer immunology. These lines can significantly enhance the understanding of the molecular mechanisms driving immune responses, paving the way for innovative therapeutic strategies.
Compared with alternative approaches, such as transient silencing or overexpression studies, CLEC2D Gene Knockout Cell Lines offer a more stable and accurate model for long-term studies. The single-gene knockout approach provides clarity in the interpretation of data, eliminating complication from off-target effects that may arise with other methods.
For researchers and clinicians alike, these cell lines represent a powerful tool that bridges fundamental research and therapeutic innovation. They are essential for those looking to explore intricate immune interactions and contribute to the advancement of targeted therapies.
Our company specializes in providing high-quality biological research tools, with a focus on cutting-edge genomic technologies. We are dedicated to supporting your research needs with products that enhance scientific discovery and accelerate advancements in health and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.